These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17999026)

  • 1. Adenosine: trigger and mediator of cardioprotection.
    Cohen MV; Downey JM
    Basic Res Cardiol; 2008 May; 103(3):203-15. PubMed ID: 17999026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping preconditioning's signaling pathways: an engineering approach.
    Downey JM; Krieg T; Cohen MV
    Ann N Y Acad Sci; 2008 Mar; 1123():187-96. PubMed ID: 18375591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosinergic cardioprotection: multiple receptors, multiple pathways.
    Peart JN; Headrick JP
    Pharmacol Ther; 2007 May; 114(2):208-21. PubMed ID: 17408751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5'-nucleotidase important?
    Iliodromitis EK; Miki T; Liu GS; Downey JM; Cohen MV; Kremastinos DT
    J Mol Cell Cardiol; 1998 Nov; 30(11):2201-11. PubMed ID: 9925358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
    Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
    J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.
    Philipp S; Yang XM; Cui L; Davis AM; Downey JM; Cohen MV
    Cardiovasc Res; 2006 May; 70(2):308-14. PubMed ID: 16545350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation.
    Yang XM; Philipp S; Downey JM; Cohen MV
    Basic Res Cardiol; 2005 Jan; 100(1):57-63. PubMed ID: 15614590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection.
    Penna C; Mancardi D; Tullio F; Pagliaro P
    J Surg Res; 2009 May; 153(2):231-8. PubMed ID: 18694574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine, adenosine receptors and myocardial protection: an updated overview.
    Mubagwa K; Flameng W
    Cardiovasc Res; 2001 Oct; 52(1):25-39. PubMed ID: 11557231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand triggers of classical preconditioning and postconditioning.
    Gross ER; Gross GJ
    Cardiovasc Res; 2006 May; 70(2):212-21. PubMed ID: 16448635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic postconditioning: from receptor to end-effector.
    Cohen MV; Downey JM
    Antioxid Redox Signal; 2011 Mar; 14(5):821-31. PubMed ID: 20518705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning modulates mitochondrial respiration, irrespective of the employed signal transduction pathway.
    Liem DA; Manintveld OC; Schoonderwoerd K; McFalls EO; Heinen A; Verdouw PD; Sluiter W; Duncker DJ
    Transl Res; 2008 Jan; 151(1):17-26. PubMed ID: 18061124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies.
    Cohen MV; Yang XM; Downey JM
    Cardiovasc Res; 2006 May; 70(2):231-9. PubMed ID: 16376869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection.
    Murphy E
    Circ Res; 2004 Jan; 94(1):7-16. PubMed ID: 14715531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial K(ATP) channels: role in cardioprotection.
    Oldenburg O; Cohen MV; Yellon DM; Downey JM
    Cardiovasc Res; 2002 Aug; 55(3):429-37. PubMed ID: 12160940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning.
    Ban K; Cooper AJ; Samuel S; Bhatti A; Patel M; Izumo S; Penninger JM; Backx PH; Oudit GY; Tsushima RG
    Circ Res; 2008 Sep; 103(6):643-53. PubMed ID: 18688045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of preconditioning.
    Das M; Das DK
    IUBMB Life; 2008 Apr; 60(4):199-203. PubMed ID: 18344203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adaptation of myocardium to ischemia. The early phase of ischemic preconditioning].
    Maslov LN; Lishmanov IuB; Solenkova NV
    Usp Fiziol Nauk; 2006; 37(3):25-41. PubMed ID: 17022466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cardioprotection by early ischemic preconditioning.
    Yang X; Cohen MV; Downey JM
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):225-34. PubMed ID: 20505987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.